enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zoledronic acid - Wikipedia

   en.wikipedia.org/wiki/Zoledronic_acid

   Zoledronic acid, also known as zoledronate and sold under the brand name Zometa among others, [7] by Novartis among others, is a medication used to treat a number of bone diseases. [3] These include osteoporosis , high blood calcium due to cancer , bone breakdown due to cancer, Paget's disease of bone [ 3 ] and Duchenne muscular dystrophy (DMD).

3. Empagliflozin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin

   Empagliflozin, sold under the brand name Jardiance (/ ˈ dʒ ɑːr d i ə n s / JAR-dee-əns), among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. [12] [2] [14] It is taken by mouth. [2]

4. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

   www.aol.com/diabetes-drugs-really-safe-reliable...

   The most common side effects of GLP-1 medications are gastrointestinal issues, including: Constipation. ... These severe adverse effects of weight loss diabetes drugs are uncommon, but they’re ...

5. Empagliflozin/linagliptin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin/linagliptin

   The most common side effects include urinary infections, nasopharyngitis, and upper respiratory tract infections . [5] [6] The most serious side effects include ketoacidosis (high blood levels of acids called ‘ketoacids’), pancreatitis (inflammation of the pancreas), hypersensitivity (allergic reactions) and hypoglycaemia (low blood sugar levels).

6. Ozempic Butt Isn't The Strangest Side Effect Of The Drug ...

   www.aol.com/ozempic-butt-isnt-strangest-side...

   The most common side effects of Ozempic stem from the fact that it slows down how food moves through your GI tract, says Florence Comite, MD, founder of the Comite Center for Precision Medicine ...

7. Empagliflozin/metformin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin/metformin

   In the United States it is also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. [ 4 ] In June 2023, the US Food and Drug Administration (FDA) expanded the indication, as an addition to diet and exercise, to improve blood sugar control in children 10 years and ...